| RS2145903433 |
COMP
|
Health Risk |
Likely pathogenic |
Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome, Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome |
| RS2145903436 |
COMP
|
Health Risk |
Conflicting classifications of pathogenicity |
Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome, Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome |
| RS2145906974 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2145906988 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2145907069 |
MAST1
|
Health Risk |
Pathogenic |
Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations, Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations |
| RS2145907078 |
MAST1
|
Health Risk |
Likely pathogenic |
Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations, Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations |
| RS2145907149 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2145909826 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2145910066 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2145910106 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2145910195 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2145910302 |
DONSON
|
Health Risk |
Pathogenic/Likely pathogenic |
Meier-Gorlin syndrome 1, Meier-Gorlin syndrome 1 |
| RS2145910842 |
ARHGEF18
|
Health Risk |
Pathogenic |
— |
| RS2145912242 |
ARHGEF18
|
Health Risk |
Pathogenic |
— |
| RS2145912754 |
PIGN
|
Health Risk |
Likely pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 1, Multiple congenital anomalies-hypotonia-seizures syndrome 1 |
| RS2145912840 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related myopathy, RYR1-related myopathy |
| RS2145913747 |
RYR1
|
Health Risk |
Likely pathogenic |
Malignant hyperthermia of anesthesia, Malignant hyperthermia of anesthesia |
| RS2145914268 |
GNAS
|
Health Risk |
Pathogenic |
Pseudohypoparathyroidism type I A, Pseudohypoparathyroidism type I A |
| RS2145914732 |
GNAS
|
Health Risk |
Pathogenic |
— |
| RS2145916486 |
GNAS
|
Health Risk |
Pathogenic |
Pseudohypoparathyroidism, Pseudopseudohypoparathyroidism |
| RS2145916749 |
GNAS
|
Health Risk |
Pathogenic |
Pseudopseudohypoparathyroidism, Pseudohypoparathyroidism |
| RS2145916852 |
GNAS
|
Health Risk |
Likely pathogenic |
Pseudohypoparathyroidism type 1C, Pseudohypoparathyroidism type I A |
| RS2145916888 |
GNAS
|
Health Risk |
Pathogenic |
Pseudohypoparathyroidism type I A, GNAS-related disorder |
| RS2145916985 |
GNAS
|
Health Risk |
Pathogenic |
Pseudohypoparathyroidism type I A, Pseudohypoparathyroidism type I A |
| RS2145917033 |
ABHD12
|
Health Risk |
Pathogenic |
— |
| RS2145917348 |
GNAS
|
Health Risk |
Pathogenic |
— |
| RS2145917373 |
RYR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Central core myopathy, RYR1-related disorder |
| RS2145918040 |
RYR1
|
Health Risk |
Likely pathogenic |
Malignant hyperthermia of anesthesia, Malignant hyperthermia of anesthesia |
| RS2145919289 |
HSF4
|
Health Risk |
Likely pathogenic |
Developmental cataract, Developmental cataract |
| RS2145919390 |
COL18A1
|
Health Risk |
Pathogenic |
— |
| RS2145920428 |
HSF4
|
Health Risk |
Pathogenic |
Cataract 5 multiple types, Cataract 5 multiple types |
| RS2145920846 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2145920950 |
ABHD12
|
Health Risk |
Likely pathogenic |
— |
| RS2145921196 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Seizures, benign familial neonatal |
| RS2145921283 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2145921332 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2145921462 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2145921549 |
DNASE2
|
Health Risk |
Pathogenic |
Autoinflammatory-pancytopenia syndrome due to DNASE2 deficiency, Autoinflammatory-pancytopenia syndrome due to DNASE2 deficiency |
| RS2145921606 |
KCNQ2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS2145921876 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2145922320 |
KCNQ2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS2145924056 |
RTTN
|
Health Risk |
Pathogenic |
— |
| RS2145925061 |
COL18A1
|
Health Risk |
Pathogenic |
— |
| RS2145927350 |
CHCHD10
|
Health Risk |
Pathogenic |
Lower motor neuron syndrome with late-adult onset, Frontotemporal dementia and/or amyotrophic lateral sclerosis 2 |
| RS2145927881 |
KLF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital dyserythropoietic anemia type 4, Congenital dyserythropoietic anemia type 4 |
| RS2145932387 |
CHEK2
|
Health Risk |
Pathogenic |
Malignant tumor of breast, Malignant tumor of breast |
| RS2145934671 |
COL18A1
|
Health Risk |
Likely pathogenic |
Knobloch syndrome, Knobloch syndrome |
| RS2145935724 |
ABHD12
|
Health Risk |
Pathogenic |
— |
| RS2145935797 |
ABHD12
|
Health Risk |
Pathogenic |
— |
| RS2145936823 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Childhood neoplasm, Hereditary cancer-predisposing syndrome |
| RS2145937134 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 16 |
| RS2145937523 |
COL18A1
|
Health Risk |
Pathogenic |
— |
| RS2145938175 |
GCDH
|
Health Risk |
Pathogenic |
Glutaric aciduria, type 1 |
| RS2145938177 |
EEF1A2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 33 |
| RS2145938426 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 16 |
| RS2145938835 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS2145940591 |
GCDH
|
Health Risk |
Pathogenic |
Glutaric aciduria, type 1 |
| RS2145941195 |
ATP1A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Dystonia 12, Dystonia 12 |
| RS2145942104 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, SMARCA4-related disorder |
| RS2145942372 |
ATP1A3
|
Health Risk |
Likely pathogenic |
Dystonia 12, Dystonia 12 |
| RS2145944277 |
GCDH
|
Health Risk |
Likely pathogenic |
Glutaric aciduria, type 1 |
| RS2145944429 |
GCDH
|
Health Risk |
Conflicting classifications of pathogenicity |
Glutaric aciduria, type 1 |
| RS2145944441 |
GREB1L
|
Health Risk |
Pathogenic |
Renal hypodysplasia/aplasia 3, Renal hypodysplasia/aplasia 3 |
| RS2145944530 |
GREB1L
|
Health Risk |
Pathogenic |
Renal hypodysplasia/aplasia 3, Renal hypodysplasia/aplasia 3 |
| RS2145944794 |
ATP1A3
|
Health Risk |
Likely pathogenic |
Dystonia 12, Dystonia 12 |
| RS2145944931 |
EEF1A2
|
Health Risk |
Likely pathogenic |
— |
| RS2145944981 |
EEF1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 33 |
| RS2145945412 |
EEF1A2
|
Health Risk |
Likely pathogenic |
— |
| RS2145945425 |
EEF1A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 33 |
| RS2145945797 |
ATP1A3
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy 99, Developmental and epileptic encephalopathy 99 |
| RS2145945805 |
ATP1A3
|
Health Risk |
Pathogenic |
Dystonia 12, Dystonia 12 |
| RS2145945849 |
ATP1A3
|
Health Risk |
Pathogenic |
Dystonia 12, Dystonia 12 |
| RS2145945887 |
ATP1A3
|
Health Risk |
Likely pathogenic |
Dystonia 12, Dystonia 12 |
| RS2145945980 |
ATP1A3
|
Health Risk |
Pathogenic |
— |
| RS2145946065 |
ATP1A3
|
Health Risk |
Pathogenic |
Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, Developmental and epileptic encephalopathy 99 |
| RS2145946848 |
EEF1A2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 33 |
| RS2145948130 |
ATP1A3
|
Health Risk |
Likely pathogenic |
— |
| RS2145948828 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2145949099 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2145949157 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2145949378 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2145949535 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2145949827 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2145950047 |
GCDH
|
Health Risk |
Pathogenic/Likely pathogenic |
Glutaric aciduria, type 1 |
| RS2145950197 |
GCDH
|
Health Risk |
Pathogenic |
Glutaric aciduria, type 1 |
| RS2145950251 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2145950460 |
GCDH
|
Health Risk |
Pathogenic/Likely pathogenic |
Glutaric aciduria, type 1 |
| RS2145950548 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2145950918 |
GCDH
|
Health Risk |
Pathogenic |
Glutaric aciduria, type 1 |
| RS2145951020 |
MYO18B
|
Health Risk |
Likely pathogenic |
Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome, Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome |
| RS2145951132 |
CHEK2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Familial cancer of breast |
| RS2145951375 |
GCDH
|
Health Risk |
Pathogenic |
Glutaric aciduria, type 1 |
| RS2145951385 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, CHEK2-related cancer predisposition |
| RS2145951528 |
CHEK2
|
Health Risk |
Likely pathogenic |
Breast carcinoma, Breast carcinoma |
| RS2145951649 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2145952062 |
SPTBN4
|
Health Risk |
Pathogenic |
— |
| RS2145952071 |
SMARCB1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2145952184 |
SMARCB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2145952190 |
SMARCB1
|
Health Risk |
Pathogenic |
— |
| RS2145952201 |
SMARCB1
|
Health Risk |
Likely pathogenic |
— |